PRTA Dividend History & Analysis | N/A Yield
PRTA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| BTX | 1,434 M | 13.5% | 7.37% |
| ABBV | 393,809 M | 3.61% | 9.74% |
| GILD | 150,721 M | 2.51% | 6.73% |
| AMGN | 174,694 M | 2.85% | 4.98% |
| HLN | 44,084 M | 1.74% | 2.46% |
| Symbol | Market Cap USD | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BTX | 1,434 M | 203% | 90.0% |
| GRFS | 7,645 M | 127% | 56.8% |
| HLN | 44,084 M | 51.0% | 100% |
| AMGN | 174,694 M | 8.90% | 100% |
| ABBV | 393,809 M | 7.06% | 100% |
Similar Stocks with Attractive Dividends - Compare PRTA Dividends with its Peer-Group
3.61% Yield
2.85% Yield
2.51% Yield
1.74% Yield
PRTA Dividend History: as of December 2025
No dividends paid yet.PRTA Dividend FAQ
Prothena Corporation plc (NASDAQ: PRTA) is a late-stage clinical biotech focused on antibodies that correct protein-misfolding disorders in the U.S. Its lead asset, prasinezumab-a humanized monoclonal antibody targeting α-synuclein-is in a Phase 2b trial for Parkinson’s disease and other synucleinopathies. The pipeline also includes Coramitug (Phase 2 for transthyretin amyloidosis), BMS-986446 (Phase 2 for Alzheimer’s), PRX012 (Phase 1 Alzheimer’s), PRX123 (preclinical dual Aβ-Tau vaccine), and PRX019 (Phase 1 for broader neurodegeneration). Strategic partnerships with Roche (α-synuclein) and Bristol Myers Squibb (tau, TDP-43) provide development and commercialization pathways.
What is the Dividend Yield of PRTA?
As of December 2025, PRTA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 9.69.Does PRTA pay a dividend?
As of December 2025 PRTA does not pay a dividend.How often does PRTA pay dividends?
Over the last 12 months, PRTA has issued dividend payments.PRTA dividend forecast
Based on historical data, the forecasted dividends per share for PRTA for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will PRTA pay dividends in 2025?
The next Ex-Dividend date for Prothena (PRTA) is currently unknown.What is the next Ex-Dividend Date for PRTA?
The next Ex-Dividend date for Prothena (PRTA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of PRTA?
PRTA's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of PRTA?
PRTA's 5-Year Yield on Cost is -%. If you bought PRTA's shares at 12.88 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of PRTA?
PRTA Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does PRTA have a good Dividend Yield?
PRTA`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of PRTA?
The Dividend Payout Ratio of PRTA is unknown.What is the Dividend Rating of PRTA?
PRTA`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-12-20 04:46